FREELINE THERAPEUTICS HLDGS's ticker is FRLN and the CUSIP is 35655L107. A total of 20 filers reported holding FREELINE THERAPEUTICS HLDGS in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $227,500 | -8.3% | 500,000 | -3.3% | 0.00% | – |
| Q4 2022 | $248,124 | -31.3% | 516,926 | +0.1% | 0.00% | – |
| Q3 2022 | $361,000 | -17.8% | 516,199 | +2.3% | 0.00% | – |
| Q2 2022 | $439,000 | -22.3% | 504,538 | -0.0% | 0.00% | – |
| Q1 2022 | $565,000 | +28150.0% | 504,714 | +100842.8% | 0.00% | – |
| Q3 2021 | $2,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 1,466,507 | $6,217,990 | 9.26% |